Results 131 to 140 of about 168,585 (146)

SEMISYNTHESIS OF PACLITAXEL AND DOCETAXELSEMISYNTHESIS OF PACLITAXEL AND DOCETAXELSEMISYNTHESIS OF PACLITAXEL AND DOCETAXELSEMISYNTHESIS OF PACLITAXEL AND DOCETAXEL

2008
ZHAN HUAXING, SHEN XIN, LIAO LIXIN, HE XIAO, LIN FUXING, YANG JIDONG   +5 more
openaire   +1 more source

Paclitaxel

Reactions Weekly, 2014
openaire   +1 more source

Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis

Critical Reviews in Oncology/Hematology, 2019
Yuhong Zhou, Hong Sun, Weimin Cai
exaly  

Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer

Annals of Oncology, 2007
David Kelsen, D P Kelsen
exaly  

Pharmacologic Sensitivity of Paclitaxel to Its Delivery Vehicles Drives Distinct Clinical Outcomes of Paclitaxel Formulations

Molecular Pharmaceutics, 2015
Maria Palmisano, Simon Zhou
exaly  

PACLITAXEL SOLVATES

2005
BENIGNI DANIEL A, GOUGOUTAS JACK Z, DIMARCO JOHN D   +2 more
openaire   +2 more sources

Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

Annals of Oncology, 2016
Mario Campone, D Pérol, C Courtinard
exaly  

Paclitaxel

Reactions Weekly, 2008
openaire   +1 more source

Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin

European Journal of Pharmaceutics and Biopharmaceutics, 2004
Jun-Shik Choi
exaly  

Paclitaxel-induced cell death

Cancer, 2000
Y K Soong
exaly